SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-032070
Filing Date
2022-11-14
Accepted
2022-11-14 16:20:53
Documents
17
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44336
2 ex99-1.htm EX-99.1 309750
3 ex99-2.htm EX-99.2 205342
4 ex99-1_001.jpg GRAPHIC 3642
5 ex99-2_001.jpg GRAPHIC 3642
  Complete submission text file 0001493152-22-032070.txt   840238

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hrow-20221114.xsd EX-101.SCH 3950
7 XBRL DEFINITION FILE hrow-20221114_def.xml EX-101.DEF 27023
8 XBRL LABEL FILE hrow-20221114_lab.xml EX-101.LAB 37280
9 XBRL PRESENTATION FILE hrow-20221114_pre.xml EX-101.PRE 25644
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5538
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 221385842
SIC: 2834 Pharmaceutical Preparations